project id: TCGA-LUAD; case submitter id: TCGA-78-7161; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; age at index: 69; days to birth: -25294; days to death: 291; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1942; age at diagnosis: 25294; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 215.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 1.5232876712328767; pack years smoked: 27.8; years smoked: 37.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-78-7161-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;